{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:04:35Z","timestamp":1757628275909,"version":"3.44.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"European Association of Neurosurgical Societies"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11060-025-05182-y","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:57:03Z","timestamp":1753711023000},"page":"825-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating levels of glutamate predict brain disease in patients with advanced lung and breast cancer: a prospective study"],"prefix":"10.1007","volume":"175","author":[{"given":"Filippo","family":"Gagliardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Roncelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Snider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierfrancesco","family":"De Domenico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina Raffaella","family":"Barzaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Bulotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Rita","family":"Ogliari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Pompeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Klungtvedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Dall\u2019Acqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Comai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Ruban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"1","key":"5182_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40478-025-02009-9","volume":"13","author":"J Mondal","year":"2025","unstructured":"Mondal J, Huse JT (2025) Neurotransmitter power plays: the synaptic communication nexus shaping brain cancer. Acta Neuropathol Commun 13(1):85","journal-title":"Acta Neuropathol Commun"},{"issue":"16","key":"5182_CR2","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","volume":"185","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wissmann N et al (2022) Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell 185(16):2899\u20132917 e31","journal-title":"Cell"},{"key":"5182_CR3","doi-asserted-by":"crossref","unstructured":"Huang Q, Chen L, Liang J, Huang Q, Sun H (2022) Neurotransmitters: potential targets in glioblastoma. Cancers (Basel). 14(16)","DOI":"10.3390\/cancers14163970"},{"key":"5182_CR4","doi-asserted-by":"publisher","first-page":"116844","DOI":"10.1016\/j.biopha.2024.116844","volume":"176","author":"Y Yang","year":"2024","unstructured":"Yang Y, Sun L, Liu X, Liu W, Zhang Z, Zhou X et al (2024) Neurotransmitters: impressive regulators of tumor progression. Biomed Pharmacother 176:116844","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5182_CR5","doi-asserted-by":"publisher","first-page":"300060520905985","DOI":"10.1177\/0300060520905985","volume":"48","author":"Y Hu","year":"2020","unstructured":"Hu Y, Xiang J, Su L, Tang X (2020) The regulation of nitric oxide in tumor progression and therapy. J Int Med Res 48(2):300060520905985","journal-title":"J Int Med Res"},{"issue":"7775","key":"5182_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","volume":"573","author":"HS Venkatesh","year":"2019","unstructured":"Venkatesh HS, Morishita W, Geraghty AC, Silverbush D, Gillespie SM, Arzt M et al (2019) Electrical and synaptic integration of glioma into neural circuits. Nature 573(7775):539\u2013545","journal-title":"Nature"},{"issue":"7775","key":"5182_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","volume":"573","author":"V Venkataramani","year":"2019","unstructured":"Venkataramani V, Tanev DI, Strahle C, Studier-Fischer A, Fankhauser L, Kessler T et al (2019) Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature 573(7775):532\u2013538","journal-title":"Nature"},{"issue":"7775","key":"5182_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","volume":"573","author":"Q Zeng","year":"2019","unstructured":"Zeng Q, Michael IP, Zhang P, Saghafinia S, Knott G, Jiao W et al (2019) Synaptic proximity enables NMDAR signalling to promote brain metastasis. Nature 573(7775):526\u2013531","journal-title":"Nature"},{"key":"5182_CR9","doi-asserted-by":"publisher","first-page":"1123841","DOI":"10.3389\/fimmu.2023.1123841","volume":"14","author":"S Koda","year":"2023","unstructured":"Koda S, Hu J, Ju X, Sun G, Shao S, Tang RX et al (2023) The role of glutamate receptors in the regulation of the tumor microenvironment. Front Immunol 14:1123841","journal-title":"Front Immunol"},{"issue":"3","key":"5182_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"Hanahan D, Monje M (2023) Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell 41(3):573\u2013580","journal-title":"Cancer Cell"},{"issue":"6","key":"5182_CR11","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270\u2013e278","journal-title":"Lancet Oncol"},{"issue":"9","key":"5182_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm0901-1010","volume":"7","author":"T Takano","year":"2001","unstructured":"Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M (2001) Glutamate release promotes growth of malignant gliomas. Nat Med 7(9):1010\u20131015","journal-title":"Nat Med"},{"issue":"2","key":"5182_CR13","doi-asserted-by":"publisher","first-page":"107500","DOI":"10.1016\/j.celrep.2020.03.064","volume":"31","author":"MK Montgomery","year":"2020","unstructured":"Montgomery MK, Kim SH, Dovas A, Zhao HT, Goldberg AR, Xu W et al (2020) Glioma-Induced alterations in neuronal activity and neurovascular coupling during disease progression. Cell Rep 31(2):107500","journal-title":"Cell Rep"},{"issue":"7","key":"5182_CR14","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.18632\/oncotarget.3243","volume":"6","author":"KH Liu","year":"2015","unstructured":"Liu KH, Yang ST, Lin YK, Lin JW, Lee YH, Wang JY et al (2015) Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis. Oncotarget 6(7):5088\u20135101","journal-title":"Oncotarget"},{"issue":"37","key":"5182_CR15","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.2174\/1381612826666200603132456","volume":"26","author":"H Mollazadeh","year":"2020","unstructured":"Mollazadeh H, Mohtashami E, Mousavi SH, Soukhtanloo M, Vahedi MM, Hosseini A et al (2020) Deciphering the role of glutamate signaling in glioblastoma multiforme: current therapeutic modalities and future directions. Curr Pharm Des 26(37):4777\u20134788","journal-title":"Curr Pharm Des"},{"key":"5182_CR16","doi-asserted-by":"crossref","unstructured":"Corsi L, Mescola A, Alessandrini A (2019) Glutamate receptors and glioblastoma multiforme: an old route for new perspectives. Int J Mol Sci. 20(7)","DOI":"10.3390\/ijms20071796"},{"issue":"3","key":"5182_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1215\/15228517-2008-094","volume":"11","author":"Y Piao","year":"2009","unstructured":"Piao Y, Lu L, de Groot J (2009) AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix. Neuro Oncol 11(3):260\u2013273","journal-title":"Neuro Oncol"},{"key":"5182_CR18","doi-asserted-by":"crossref","unstructured":"Muller-Langle A, Lutz H, Hehlgans S, Rodel F, Rau K, Laube B (2019) NMDA Receptor-Mediated signaling pathways enhance radiation resistance, survival and migration in glioblastoma Cells-A potential target for adjuvant radiotherapy. Cancers (Basel). 11(4)","DOI":"10.3390\/cancers11040503"},{"issue":"3","key":"5182_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1215\/S1152851704000961","volume":"7","author":"A Arcella","year":"2005","unstructured":"Arcella A, Carpinelli G, Battaglia G, D\u2019Onofrio M, Santoro F, Ngomba RT et al (2005) Pharmacological Blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Neuro Oncol 7(3):236\u2013245","journal-title":"Neuro Oncol"},{"issue":"13","key":"5182_CR20","doi-asserted-by":"publisher","first-page":"22279","DOI":"10.18632\/oncotarget.15299","volume":"8","author":"MSL Pereira","year":"2017","unstructured":"Pereira MSL, Klamt F, Thome CC, Worm PV, de Oliveira DL (2017) Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas. Oncotarget 8(13):22279\u201322298","journal-title":"Oncotarget"},{"key":"5182_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fnins.2018.00320","volume":"12","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Zheng X, Luan Y, Liu Y, Li X, Liu C et al (2018) Activity of metabotropic glutamate receptor 4 suppresses proliferation and promotes apoptosis with Inhibition of Gli-1 in human glioblastoma cells. Front Neurosci 12:320","journal-title":"Front Neurosci"},{"issue":"2","key":"5182_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11060-008-9552-2","volume":"88","author":"JF de Groot","year":"2008","unstructured":"de Groot JF, Piao Y, Lu L, Fuller GN, Yung WK (2008) Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol 88(2):121\u2013133","journal-title":"J Neurooncol"},{"issue":"2","key":"5182_CR23","doi-asserted-by":"publisher","first-page":"e0211644","DOI":"10.1371\/journal.pone.0211644","volume":"14","author":"F Lange","year":"2019","unstructured":"Lange F, Wesslau K, Porath K, Hornschemeyer MF, Bergner C, Krause BJ et al (2019) AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro. PLoS ONE 14(2):e0211644","journal-title":"PLoS ONE"},{"issue":"8","key":"5182_CR24","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/j.1528-1167.2012.03557.x","volume":"53","author":"SL Campbell","year":"2012","unstructured":"Campbell SL, Buckingham SC, Sontheimer H (2012) Human glioma cells induce hyperexcitability in cortical networks. Epilepsia 53(8):1360\u20131370","journal-title":"Epilepsia"},{"issue":"4","key":"5182_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","volume":"161","author":"HS Venkatesh","year":"2015","unstructured":"Venkatesh HS, Johung TB, Caretti V, Noll A, Tang Y, Nagaraja S et al (2015) Neuronal activity promotes glioma growth through Neuroligin-3 secretion. Cell 161(4):803\u2013816","journal-title":"Cell"},{"issue":"7862","key":"5182_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-021-03580-6","volume":"594","author":"Y Pan","year":"2021","unstructured":"Pan Y, Hysinger JD, Barron T, Schindler NF, Cobb O, Guo X et al (2021) NF1 mutation drives neuronal activity-dependent initiation of optic glioma. Nature 594(7862):277\u2013282","journal-title":"Nature"},{"issue":"7673","key":"5182_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","volume":"549","author":"HS Venkatesh","year":"2017","unstructured":"Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM et al (2017) Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature 549(7673):533\u2013537","journal-title":"Nature"},{"issue":"10","key":"5182_CR28","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm.2453","volume":"17","author":"SC Buckingham","year":"2011","unstructured":"Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T et al (2011) Glutamate release by primary brain tumors induces epileptic activity. Nat Med 17(10):1269\u20131274","journal-title":"Nat Med"},{"issue":"7971","key":"5182_CR29","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41586-023-06267-2","volume":"619","author":"E Huang-Hobbs","year":"2023","unstructured":"Huang-Hobbs E, Cheng YT, Ko Y, Luna-Figueroa E, Lozzi B, Taylor KR et al (2023) Remote neuronal activity drives glioma progression through SEMA4F. Nature 619(7971):844\u2013850","journal-title":"Nature"},{"issue":"2","key":"5182_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.devcel.2022.12.011","volume":"58","author":"C Anastasaki","year":"2023","unstructured":"Anastasaki C, Gao Y, Gutmann DH (2023) Neurons as stromal drivers of nervous system cancer formation and progression. Dev Cell 58(2):81\u201393","journal-title":"Dev Cell"},{"issue":"1","key":"5182_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/glia.22730","volume":"63","author":"SL Campbell","year":"2015","unstructured":"Campbell SL, Robel S, Cuddapah VA, Robert S, Buckingham SC, Kahle KT et al (2015) GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy. Glia 63(1):23\u201336","journal-title":"Glia"},{"issue":"7986","key":"5182_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","volume":"623","author":"KR Taylor","year":"2023","unstructured":"Taylor KR, Barron T, Hui A, Spitzer A, Yalcin B, Ivec AE et al (2023) Glioma synapses recruit mechanisms of adaptive plasticity. Nature 623(7986):366\u2013374","journal-title":"Nature"},{"issue":"7580","key":"5182_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature16071","volume":"528","author":"M Osswald","year":"2015","unstructured":"Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J et al (2015) Brain tumour cells interconnect to a functional and resistant network. Nature 528(7580):93\u201398","journal-title":"Nature"},{"issue":"1","key":"5182_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cell.2013.02.051","volume":"153","author":"L Li","year":"2013","unstructured":"Li L, Hanahan D (2013) Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion. Cell 153(1):86\u2013100","journal-title":"Cell"},{"issue":"2","key":"5182_CR35","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang D, Wang Y, Thompson JW, Yin T, Alexander PB, Qin D et al (2022) Cancer-cell-derived GABA promotes beta-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol 24(2):230\u2013241","journal-title":"Nat Cell Biol"},{"issue":"5","key":"5182_CR36","doi-asserted-by":"publisher","first-page":"e37041","DOI":"10.1371\/journal.pone.0037041","volume":"7","author":"A Smits","year":"2012","unstructured":"Smits A, Jin Z, Elsir T, Pedder H, Nister M, Alafuzoff I et al (2012) GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome. PLoS ONE 7(5):e37041","journal-title":"PLoS ONE"},{"issue":"6","key":"5182_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/onc.2016.245","volume":"36","author":"A Blanchart","year":"2017","unstructured":"Blanchart A, Fernando R, Haring M, Assaife-Lopes N, Romanov RA, Andang M et al (2017) Endogenous GAB(AA) receptor activity suppresses glioma growth. Oncogene 36(6):777\u2013786","journal-title":"Oncogene"},{"issue":"1","key":"5182_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12967-021-02880-9","volume":"19","author":"L Wang","year":"2021","unstructured":"Wang L, Liu Y, Yu Z, Gong J, Deng Z, Ren N et al (2021) Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1. J Transl Med 19(1):213","journal-title":"J Transl Med"},{"key":"5182_CR39","doi-asserted-by":"publisher","first-page":"114410","DOI":"10.1016\/j.biopha.2023.114410","volume":"161","author":"Y Yang","year":"2023","unstructured":"Yang Y, Ren L, Li W, Zhang Y, Zhang S, Ge B et al (2023) GABAergic signaling as a potential therapeutic target in cancers. Biomed Pharmacother 161:114410","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5182_CR40","first-page":"228","volume":"41","author":"PI D\u2019Urso","year":"2012","unstructured":"D\u2019Urso PI, D\u2019Urso OF, Storelli C, Mallardo M, Gianfreda CD, Montinaro A et al (2012) miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. Int J Oncol 41(1):228\u2013234","journal-title":"Int J Oncol"},{"issue":"1\u20132","key":"5182_CR41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2014.03.006","volume":"348","author":"D Zhang","year":"2014","unstructured":"Zhang D, Li X, Yao Z, Wei C, Ning N, Li J (2014) GABAergic signaling facilitates breast cancer metastasis by promoting ERK1\/2-dependent phosphorylation. Cancer Lett 348(1\u20132):100\u2013108","journal-title":"Cancer Lett"},{"issue":"3","key":"5182_CR42","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1073\/pnas.1322098111","volume":"111","author":"J Neman","year":"2014","unstructured":"Neman J, Termini J, Wilczynski S, Vaidehi N, Choy C, Kowolik CM et al (2014) Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc Natl Acad Sci U S A 111(3):984\u2013989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5182_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11306-021-01864-6","volume":"18","author":"ML Dahn","year":"2022","unstructured":"Dahn ML, Walsh HR, Dean CA, Giacomantonio MA, Fernando W, Murphy JP et al (2022) Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis. Metabolomics 18(1):9","journal-title":"Metabolomics"},{"issue":"1","key":"5182_CR44","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1038\/s41598-023-32302-3","volume":"13","author":"S Snider","year":"2023","unstructured":"Snider S, Albano L, Gagliardi F, Comai S, Roncelli F, De Domenico P et al (2023) Substantially elevated serum glutamate and CSF GOT-1 levels associated with cerebral ischemia and poor neurological outcomes in subarachnoid hemorrhage patients. Sci Rep 13(1):5246","journal-title":"Sci Rep"},{"issue":"5","key":"5182_CR45","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1515\/cclm-2011-0846","volume":"50","author":"T Kouchiwa","year":"2012","unstructured":"Kouchiwa T, Wada K, Uchiyama M, Kasezawa N, Niisato M, Murakami H et al (2012) Age-related changes in serum amino acids concentrations in healthy individuals. Clin Chem Lab Med 50(5):861\u2013870","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"5182_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/ANA.0b013e3181f82a8f","volume":"23","author":"A Zlotnik","year":"2011","unstructured":"Zlotnik A, Ohayon S, Gruenbaum BF, Gruenbaum SE, Mohar B, Boyko M et al (2011) Determination of factors affecting glutamate concentrations in the whole blood of healthy human volunteers. J Neurosurg Anesthesiol 23(1):45\u201349","journal-title":"J Neurosurg Anesthesiol"},{"issue":"2","key":"5182_CR47","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1528-1157.1993.tb02420.x","volume":"34","author":"ML Rao","year":"1993","unstructured":"Rao ML, Stefan H, Scheid C, Kuttler AD, Froscher W (1993) Serum amino acids, liver status, and antiepileptic drug therapy in epilepsy. Epilepsia 34(2):347\u2013354","journal-title":"Epilepsia"},{"issue":"21","key":"5182_CR48","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1158\/1078-0432.CCR-12-1308","volume":"18","author":"S Koochekpour","year":"2012","unstructured":"Koochekpour S, Majumdar S, Azabdaftari G, Attwood K, Scioneaux R, Subramani D et al (2012) Serum glutamate levels correlate with Gleason score and glutamate Blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res 18(21):5888\u20135901","journal-title":"Clin Cancer Res"},{"issue":"2","key":"5182_CR49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/aja.2012.145","volume":"15","author":"S Koochekpour","year":"2013","unstructured":"Koochekpour S (2013) Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer. Asian J Androl 15(2):212\u2013213","journal-title":"Asian J Androl"},{"key":"5182_CR50","doi-asserted-by":"publisher","first-page":"2895972","DOI":"10.1155\/2016\/2895972","volume":"2016","author":"S Michalak","year":"2016","unstructured":"Michalak S, Rybacka-Mossakowska J, Ambrosius W, Gazdulska J, Golda-Gocka I, Kozubski W et al (2016) The markers of glutamate metabolism in peripheral blood mononuclear cells and neurological complications in lung cancer patients. Dis Markers 2016:2895972","journal-title":"Dis Markers"},{"issue":"5","key":"5182_CR51","first-page":"100318","volume":"3","author":"MD Pichert","year":"2022","unstructured":"Pichert MD, Canavan ME, Maduka RC, Li AX, Ermer T, Zhan PL et al (2022) Revisiting indications for brain imaging during the clinical staging evaluation of lung cancer. JTO Clin Res Rep 3(5):100318","journal-title":"JTO Clin Res Rep"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05182-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05182-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05182-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:57:39Z","timestamp":1757487459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05182-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5182"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05182-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of IRCCS Ospedale San Raffaele, Milan, Italy (protocol number: NCH 04-2020). Written informed consent was obtained from all participants in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study does not include individual patient data in any form (text, images, or videos).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Neither the paper nor any part of its essential substance has been published or submitted for publication in other medical journals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Originality declaration"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}